These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 748095)

  • 21. Effects of iron loading and bacillus Calmette-Guerin on a glycoprotein recognition system on rat hepatic sinusoidal cells.
    Parise ER; Taylor ME; Summerfield JA
    J Lab Clin Med; 1984 Dec; 104(6):908-20. PubMed ID: 6502002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic recognition and catabolism of serum glycoproteins.
    Ashwell G; Steer CJ
    JAMA; 1981 Nov; 246(20):2358-64. PubMed ID: 6271991
    [No Abstract]   [Full Text] [Related]  

  • 23. Carbohydrate, protein and glycoprotein metabolism by the guinea-pig liver in chronic metribuzin poisoning.
    Tomaszewski J; Zwierz K; Mnich Z; Jezyna C
    Acta Biol Hung; 1985; 36(1):15-23. PubMed ID: 2938375
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Asialoglycoprotein clearance in the chicken: evidence for the lack of a hepatic asialoglycoprotein receptor.
    Regoeczi E; Hatton MW
    Can J Physiol Pharmacol; 1976 Feb; 54(1):27-34. PubMed ID: 1260513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Some biochemical characteristics of rat liver and Morris hepatoma nuclei and nuclear membranes.
    Spangler M; Coetzee ML; Katyal SL; Morris HP; Ove P
    Cancer Res; 1975 Nov; 35(11 Pt 1):3131-5. PubMed ID: 171064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metabolism of interferon: hepatic clearance of native and desialylated interferon.
    Bocci V; Pacini A; Pessina GP; Bargigli V; Russi M
    J Gen Virol; 1977 Jun; 35(3):525-34. PubMed ID: 881617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma binding of an alpha-blocking agent, nicergoline--affinity for serum albumin and native and modified alpha 1-acid glycoprotein.
    Robert L; Migne J; Santonja R; Zini R; Schmid K; Tillement JP
    Int J Clin Pharmacol Ther Toxicol; 1983 Jun; 21(6):271-6. PubMed ID: 6885199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of glycoprotein catabolism in vivo and in the perfused rat liver.
    Dunn WA; Aronson NN
    Acta Biol Med Ger; 1977; 36(11-12):1917-21. PubMed ID: 80903
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative and qualitative changes of plasma membrane glycoproteins in the early period of liver regeneration.
    Enrich C; Bachs O; Rius E; Serratosa J; Domingo J
    Cell Biochem Funct; 1984 Oct; 2(4):269-75. PubMed ID: 6518626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Unique distribution of glycoprotein receptors on parenchymal and sinusoidal cells of rat liver.
    Steer CJ; Clarenburg R
    J Biol Chem; 1979 Jun; 254(11):4457-61. PubMed ID: 438199
    [No Abstract]   [Full Text] [Related]  

  • 31. Incorporation of glucose-C14 into plasma glycoprotein fractions by the isolated rat liver.
    SARCIONE EJ
    Biochemistry; 1962 Nov; 1():1132-6. PubMed ID: 13991473
    [No Abstract]   [Full Text] [Related]  

  • 32. Serum glycoproteins in the liver diseases. I. Studies on sialic acid-free glycoproteins-improved competitive binding assay of desialylated glycoprotein by rat liver plasma membrane.
    Arima T; Motoyama Y; Nagata K; Kondo T
    Gastroenterol Jpn; 1976; 11(4):300-6. PubMed ID: 1017592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement of circulating desialylated glycoproteins and correlation with hepatocellular damage.
    Marshall JS; Green AM; Pensky J; Williams S; Zinn A; Carlson DM
    J Clin Invest; 1974 Sep; 54(3):555-62. PubMed ID: 4137057
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Binding of drugs to alpha 1-acid glycoprotein and its desialylated form. Influence on hepatic disposition and implications for drug targeting to the liver.
    Meijer DK; van der Sluijs P
    Prog Clin Biol Res; 1989; 300():143-67. PubMed ID: 2674961
    [No Abstract]   [Full Text] [Related]  

  • 35. The dual role of sialic acid in the hepatic recognition and catabolism of serum glycoproteins.
    Ashwell G; Morell A
    Biochem Soc Symp; 1974; (40):117-24. PubMed ID: 4620379
    [No Abstract]   [Full Text] [Related]  

  • 36. Serum glycoproteins in the liver diseases. VI. The presence of desialylated glycoprotein binding activity in particulate fraction of human liver homogenate.
    Arima T; Kondo T; Nagashima H
    Gastroenterol Jpn; 1978; 13(6):507-11. PubMed ID: 748095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum glycoproteins in the liver diseases. VII. Further studies on the properties of desialylated glycoprotein binding activity in particulate fraction of human liver homogenate.
    Arima T
    Gastroenterol Jpn; 1979 Aug; 14(4):344-8. PubMed ID: 39866
    [TBL] [Abstract][Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.